microconstants china inc
MicroConstants China Licenses Liver Cancer Drug From Pertinax Therapeutics
MicroConstants China Inc. has licensed the China rights for a Phase II liver cancer drug candidate, PTX-9908, from Pertinax Therapeutics of Canada.



